European CHMP recommends license extension for ceftazidime / avibactam (Zavicefta)

The license extension is for treatment of patients with bacteraemia. Ceftazidime / avibactam is currently licensed only for complicated intra-abdominal infection, urinary tract infection and hospital-acquired pneumonia.

Source:

European Medicines Agency